CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
embrace devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01430130
NCT01430130N/ACompleted
CompareCT.gov

Investigation of a Novel Mechanomodulating Polymer to Maximize the Outcomes of Scar Revision Procedures

Neodyne Biosciences, Inc.·interventional·Posted Sep 7, 2011·Updated Nov 28, 2014

In Brief

A clinical study evaluating embrace device for Hypertrophic. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Neodyne has developed an investigational dressing for post-operative incision care. Neodyne is conducting this research to study whether the investigational dressing, called the Neodyne Dressing, can minimize scar formation in a simple manner.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertrophic
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 7, 2011
Enrollment StartSep 1, 2011
Primary CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.8 years ago

Interventions

embrace devicedevice

Adhesive bandage/dressing intended to minimize scar formation.